CN109875963B - 一种头孢曲松钠注射液及其制备方法 - Google Patents
一种头孢曲松钠注射液及其制备方法 Download PDFInfo
- Publication number
- CN109875963B CN109875963B CN201910238060.XA CN201910238060A CN109875963B CN 109875963 B CN109875963 B CN 109875963B CN 201910238060 A CN201910238060 A CN 201910238060A CN 109875963 B CN109875963 B CN 109875963B
- Authority
- CN
- China
- Prior art keywords
- ceftriaxone sodium
- injection
- membrane material
- liposome membrane
- fatty acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Landscapes
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Description
Claims (2)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201910238060.XA CN109875963B (zh) | 2019-03-27 | 2019-03-27 | 一种头孢曲松钠注射液及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201910238060.XA CN109875963B (zh) | 2019-03-27 | 2019-03-27 | 一种头孢曲松钠注射液及其制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN109875963A CN109875963A (zh) | 2019-06-14 |
CN109875963B true CN109875963B (zh) | 2021-03-30 |
Family
ID=66934707
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201910238060.XA Active CN109875963B (zh) | 2019-03-27 | 2019-03-27 | 一种头孢曲松钠注射液及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN109875963B (zh) |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101474155A (zh) * | 2009-01-24 | 2009-07-08 | 重庆医科大学 | 注射用肺靶向载药前体脂质体及其使用方法 |
CN102716082A (zh) * | 2012-06-29 | 2012-10-10 | 海南灵康制药有限公司 | 一种头孢西丁钠脂质体注射剂 |
CN103142484A (zh) * | 2013-03-12 | 2013-06-12 | 广东药学院 | 一种非诺贝特脂质立方液晶固体粉末及其制备方法 |
CN107095874A (zh) * | 2017-04-20 | 2017-08-29 | 广东金城金素制药有限公司 | 一种小儿用C18H16N8Na2O7S33.5H2O药物实体组合物及制剂 |
WO2018081072A1 (en) * | 2016-10-25 | 2018-05-03 | The Regents Of The University Of Michigan | Design and composition of cell-stabilized pharmaceutical formulations |
CN109432009A (zh) * | 2018-12-14 | 2019-03-08 | 天津青松华药医药有限公司 | 一种头孢匹胺钠脂质体及其制备方法和应用 |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2012103328A1 (en) * | 2011-01-26 | 2012-08-02 | The Methodist Hospital Research Institute | Labeled, non- peptidic multivalent integrin alpha -v - beta - 3 antagonists, compositions containing them and their use |
-
2019
- 2019-03-27 CN CN201910238060.XA patent/CN109875963B/zh active Active
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101474155A (zh) * | 2009-01-24 | 2009-07-08 | 重庆医科大学 | 注射用肺靶向载药前体脂质体及其使用方法 |
CN102716082A (zh) * | 2012-06-29 | 2012-10-10 | 海南灵康制药有限公司 | 一种头孢西丁钠脂质体注射剂 |
CN103142484A (zh) * | 2013-03-12 | 2013-06-12 | 广东药学院 | 一种非诺贝特脂质立方液晶固体粉末及其制备方法 |
WO2018081072A1 (en) * | 2016-10-25 | 2018-05-03 | The Regents Of The University Of Michigan | Design and composition of cell-stabilized pharmaceutical formulations |
CN107095874A (zh) * | 2017-04-20 | 2017-08-29 | 广东金城金素制药有限公司 | 一种小儿用C18H16N8Na2O7S33.5H2O药物实体组合物及制剂 |
CN109432009A (zh) * | 2018-12-14 | 2019-03-08 | 天津青松华药医药有限公司 | 一种头孢匹胺钠脂质体及其制备方法和应用 |
Non-Patent Citations (2)
Title |
---|
Preparation and Characterization of New Liposomes.;Moya et al.;《Pharmaceutics》;20190206;第11卷(第2期);第69页 * |
γ-氨基丁酸和头孢曲松钠脂质体制备技术的研究;刘永坤;《中国优秀硕士学位论文全文数据库 工程科技I辑》;20110515(第5期);B016-84 * |
Also Published As
Publication number | Publication date |
---|---|
CN109875963A (zh) | 2019-06-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP6316846B2 (ja) | ポリミキシン含有組成物 | |
JP2009507049A (ja) | リン脂質のポリエチレングリコール誘導体に包み込まれたビンカアルカロイド系制癌剤のナノミセル製剤 | |
US20070116770A1 (en) | Tazobactam/piperacillin lyophilizate | |
JP3200604B2 (ja) | 菌体内毒素誘発作用抑制方法 | |
CN110464846B (zh) | 一种美洛昔康组合物、制剂及其制备方法与应用 | |
CA2949328C (en) | Low substituted polymyxins and compositions thereof | |
CN109875963B (zh) | 一种头孢曲松钠注射液及其制备方法 | |
JP2013520481A (ja) | タンパク質製剤 | |
ES2822943T3 (es) | Composiciones | |
CN107412232B (zh) | 一种小儿用C20H18N6Na2O7S4药物实体组合物及制剂 | |
US7795207B2 (en) | Lipopeptide compositions | |
CN103919744B (zh) | 一种头孢特仑新戊酯片及其制备工艺 | |
KR101019769B1 (ko) | 경구 흡수성이 개선된 항균성 약제학적 조성물 | |
CN110974937B (zh) | 一种多粘菌素e脂质体及其制备方法和应用 | |
CN107095874B (zh) | 一种小儿用药物组合物及制剂 | |
CN107693491B (zh) | 一种小儿用药物组合物及制剂 | |
BR102012020929B1 (pt) | Composição farmacêutica para a preparação de soluções de infusão de preparações antimicrobianas, seu processo de produção (variações) | |
CN112755175A (zh) | 一种抗菌肽液体组合物及其制剂 | |
JP4461727B2 (ja) | 外用剤組成物 | |
KR20070085277A (ko) | 안정화 류코트리엔 b₄(ltb₄)제의 약학 제형 | |
CN107115345B (zh) | 一种小儿用药物组合物及制剂 | |
AU2006314942A1 (en) | Lipopeptide compositions | |
JPH02209807A (ja) | 抗炎症剤 | |
RU2380405C2 (ru) | Способ получения рекомбинантного альфа 16-интерферона человека и фармацевтическая композиция для лечения вирусных заболеваний на основе рекомбинантного альфа 16-интерферона человека | |
JP2003300885A (ja) | 抗菌性医薬組成物 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
EE01 | Entry into force of recordation of patent licensing contract |
Application publication date: 20190614 Assignee: Yongfeng Shangfeng Pharmaceutical Co.,Ltd. Assignor: SHANGHAI XINFENG PHARMACEUTICAL Co.,Ltd. Contract record no.: X2021310000013 Denomination of invention: A ceftriaxone sodium injection and its preparation method Granted publication date: 20210330 License type: Exclusive License Record date: 20210407 |
|
EE01 | Entry into force of recordation of patent licensing contract | ||
EC01 | Cancellation of recordation of patent licensing contract |
Assignee: Yongfeng Shangfeng Pharmaceutical Co.,Ltd. Assignor: SHANGHAI XINFENG PHARMACEUTICAL Co.,Ltd. Contract record no.: X2021310000013 Date of cancellation: 20220110 |
|
EC01 | Cancellation of recordation of patent licensing contract |